Genmab — Januar 2018
-
jeg syntes den har været underlig siden først i oktober , og ser frem til at den bliver normal igen ,,, når shorterne forhåbentlig har fået en over snuden
-
-
-
Nogen der kan sætte et par ord på hvad konklusionen er på dette?
-
Bivirkningsmæssigt er V en smule mildere end K, men i Endeavor-studiet var der alligevel færre patienter i K-armen, der afbrød pga bivirkninger. http://www.bloodjournal.org/content/126/23/30?sso-checked=true
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
